Table-I.
Frequency of ER, PR and Her2Neu receptors and their associations with type, grade and stage of the tumor (n= 56).
| Patient Characteristics | Estrogen Receptor | Progesterone Receptor | Her2Neu | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Positive(%) | Negative (%) | p-value | Positive(%) | Negative(%) | p-value | Positive(%) | Negative(%) | p-value | |
| Histological Types | |||||||||
| Endometriod Adenocarcinoma | 24(42.85) | 25(44.6) | 0.351 | 33(58.9) | 16(28.6) | 0.604 | 2(3.6) | 47(8.9) | 0.002 |
| Serous Ca | 0(0) | 3(5.4) | 2(3.6) | 1(1.8) | 2(3.6) | 1(1.8) | |||
| Clear Cell Ca | 0(0) | 1(1.8) | 0(0) | 1(1.8) | 0(0) | 1(1.8) | |||
| Mucinous Ca | 0(0) | 1(1.8) | 1(1.8) | 0(0) | 0(0) | 1(1.8) | |||
| Carcinosarcoma | 1(1.8) | 1(1.8) | 1(1.8) | 1(1.8) | 0(0) | 2(3.6) | |||
| Grading | |||||||||
| I | 11((19.6) | 17(0.4) | 0.222 | 17(30.4) | 11(19.6) | 0.538 | 0(0) | 28(50.0) | 0.000 |
| II | 9(16) | 7(12.5) | 13(23.2) | 3(5.4) | 0(0) | 16(28.6) | |||
| III | 05(8.9) | 7(12. 5) | 7(12.5) | 5(8.9) | 4(7.1) | 8(14.3) | |||
| Staging | |||||||||
| I | 19(33.9) | 21(37.5) | 0.519 | 27(48.2) | 13(23.2) | 0.668 | 3(5.4) | 37(66.1) | 0.774 |
| II | 3(5.4) | 5(8.9) | 4(7.1) | 4(7.1) | 0(0) | 8(14.3). | |||
| III | 2(3.6) | 5(8.9) | 5(8.9) | 2(3.6) | 1(1.8) | 6(10.7) | |||
| IV | 1(1.8) | 0(0) | 1(1.8) | 0(0) | 0(0) | 1(1.8) | |||
p≤0.05 considered significant.